The up-regulation of HLA-class I would render the metastatic NB cells susceptible to cytotoxic CD8+ T cells, but the simultaneous up-regulation of PD-L1, the ligand for the immune check point PD-1, blocks the potential immune response. The gene discussed is CD274; the disease is neuroblastoma.